Cargando…
Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic
Since the beginning of the COVID-19 pandemic, counting infected people has underestimated asymptomatic cases. This literature scoping review assessed the seroprevalence progression in general populations worldwide over the first year of the pandemic. Seroprevalence studies were searched in PubMed, W...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118383/ https://www.ncbi.nlm.nih.gov/pubmed/37075077 http://dx.doi.org/10.1371/journal.pone.0269104 |
_version_ | 1785028796825468928 |
---|---|
author | Metzger, Clémentine Leroy, Taylor Bochnakian, Agathe Jeulin, Hélène Gegout-Petit, Anne Legrand, Karine Schvoerer, Evelyne Guillemin, Francis |
author_facet | Metzger, Clémentine Leroy, Taylor Bochnakian, Agathe Jeulin, Hélène Gegout-Petit, Anne Legrand, Karine Schvoerer, Evelyne Guillemin, Francis |
author_sort | Metzger, Clémentine |
collection | PubMed |
description | Since the beginning of the COVID-19 pandemic, counting infected people has underestimated asymptomatic cases. This literature scoping review assessed the seroprevalence progression in general populations worldwide over the first year of the pandemic. Seroprevalence studies were searched in PubMed, Web of Science and medRxiv databases up to early April 2021. Inclusion criteria were a general population of all ages or blood donors as a proxy. All articles were screened for the title and abstract by two readers, and data were extracted from selected articles. Discrepancies were resolved with a third reader. From 139 articles (including 6 reviews), the seroprevalence estimated in 41 countries ranged from 0 to 69%, with a heterogenous increase over time and continents, unevenly distributed among countries (differences up to 69%) and sometimes among regions within a country (up to 10%). The seroprevalence of asymptomatic cases ranged from 0% to 31.5%. Seropositivity risk factors included low income, low education, low smoking frequency, deprived area residency, high number of children, densely populated centres, and presence of a case in a household. This review of seroprevalence studies over the first year of the pandemic documented the progression of this virus across the world in time and space and the risk factors that influenced its spread. |
format | Online Article Text |
id | pubmed-10118383 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-101183832023-04-21 Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic Metzger, Clémentine Leroy, Taylor Bochnakian, Agathe Jeulin, Hélène Gegout-Petit, Anne Legrand, Karine Schvoerer, Evelyne Guillemin, Francis PLoS One Research Article Since the beginning of the COVID-19 pandemic, counting infected people has underestimated asymptomatic cases. This literature scoping review assessed the seroprevalence progression in general populations worldwide over the first year of the pandemic. Seroprevalence studies were searched in PubMed, Web of Science and medRxiv databases up to early April 2021. Inclusion criteria were a general population of all ages or blood donors as a proxy. All articles were screened for the title and abstract by two readers, and data were extracted from selected articles. Discrepancies were resolved with a third reader. From 139 articles (including 6 reviews), the seroprevalence estimated in 41 countries ranged from 0 to 69%, with a heterogenous increase over time and continents, unevenly distributed among countries (differences up to 69%) and sometimes among regions within a country (up to 10%). The seroprevalence of asymptomatic cases ranged from 0% to 31.5%. Seropositivity risk factors included low income, low education, low smoking frequency, deprived area residency, high number of children, densely populated centres, and presence of a case in a household. This review of seroprevalence studies over the first year of the pandemic documented the progression of this virus across the world in time and space and the risk factors that influenced its spread. Public Library of Science 2023-04-19 /pmc/articles/PMC10118383/ /pubmed/37075077 http://dx.doi.org/10.1371/journal.pone.0269104 Text en © 2023 Metzger et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Metzger, Clémentine Leroy, Taylor Bochnakian, Agathe Jeulin, Hélène Gegout-Petit, Anne Legrand, Karine Schvoerer, Evelyne Guillemin, Francis Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic |
title | Seroprevalence and SARS-CoV-2 invasion in general populations: A
scoping review over the first year of the pandemic |
title_full | Seroprevalence and SARS-CoV-2 invasion in general populations: A
scoping review over the first year of the pandemic |
title_fullStr | Seroprevalence and SARS-CoV-2 invasion in general populations: A
scoping review over the first year of the pandemic |
title_full_unstemmed | Seroprevalence and SARS-CoV-2 invasion in general populations: A
scoping review over the first year of the pandemic |
title_short | Seroprevalence and SARS-CoV-2 invasion in general populations: A
scoping review over the first year of the pandemic |
title_sort | seroprevalence and sars-cov-2 invasion in general populations: a
scoping review over the first year of the pandemic |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118383/ https://www.ncbi.nlm.nih.gov/pubmed/37075077 http://dx.doi.org/10.1371/journal.pone.0269104 |
work_keys_str_mv | AT metzgerclementine seroprevalenceandsarscov2invasioningeneralpopulationsascopingreviewoverthefirstyearofthepandemic AT leroytaylor seroprevalenceandsarscov2invasioningeneralpopulationsascopingreviewoverthefirstyearofthepandemic AT bochnakianagathe seroprevalenceandsarscov2invasioningeneralpopulationsascopingreviewoverthefirstyearofthepandemic AT jeulinhelene seroprevalenceandsarscov2invasioningeneralpopulationsascopingreviewoverthefirstyearofthepandemic AT gegoutpetitanne seroprevalenceandsarscov2invasioningeneralpopulationsascopingreviewoverthefirstyearofthepandemic AT legrandkarine seroprevalenceandsarscov2invasioningeneralpopulationsascopingreviewoverthefirstyearofthepandemic AT schvoererevelyne seroprevalenceandsarscov2invasioningeneralpopulationsascopingreviewoverthefirstyearofthepandemic AT guilleminfrancis seroprevalenceandsarscov2invasioningeneralpopulationsascopingreviewoverthefirstyearofthepandemic |